CG
ABBV icon

Cleary Gull’s AbbVie ABBV Stock Holding History

Cleary Gull’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$47K Buy
+805
New +$48.6K 0.04% 36

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cleary Gull's ABBV Position: Q1 2015 in Review

Cleary Gull opened a new position in AbbVie (ABBV) in Q1 2015: 805 shares worth $47K. The stake represents 0.04% of the portfolio and ranks #36 among its holdings.

1,600 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

  • Cleary Gull held 805 shares of AbbVie worth $47K as of Q1 2015.
  • AbbVie was a new Cleary Gull position in Q1 2015.
  • AbbVie made up 0.04% of Cleary Gull's portfolio in Q1 2015, its #36 holding.
  • 1,600 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Cleary Gull's 13F filing for Q1 2015, filed 13 May 2015.